These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 4212445)
1. The rejection of malignant and non-malignant homografts: a new hypothesis. Stein-Werblowsky R Oncology; 1974; 29(5):439-48. PubMed ID: 4212445 [No Abstract] [Full Text] [Related]
3. The migration of lymphoid cells in malignant disease. Stein-Werblowsky R Experientia; 1974 Apr; 30(4):422-3. PubMed ID: 4837632 [No Abstract] [Full Text] [Related]
4. The role of immunology in the diagnosis and treatment of cancer. Humphrey LJ; Pierce GE Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858 [No Abstract] [Full Text] [Related]
6. A new horizon in cancer therapy: Immunotherapy. II. Thompson RB J Miss State Med Assoc; 1972 Jan; 13(1):10-3. PubMed ID: 4550110 [No Abstract] [Full Text] [Related]
7. Assessment of the cellular immune response to HL-A antigens in human renal allograft recipients. Falk RE; Guttmann RD; Falk JA; Beaudoin JG; Deveber G; Morehouse DD; Wilson DR Clin Exp Immunol; 1973 May; 14(1):47-56. PubMed ID: 4577287 [TBL] [Abstract][Full Text] [Related]
8. Common aspects of immunologic tolerance in pregnancy and malignancy. Gleicher N; Deppe G; Cohen CJ Obstet Gynecol; 1979 Sep; 54(3):335-42. PubMed ID: 382002 [TBL] [Abstract][Full Text] [Related]
9. Effect of whole and lysed sensitized lymphocytes on murine tumor growth and host survival. Greco RS; Schmidt DR; Storer EH Surg Forum; 1973; 24():109-11. PubMed ID: 4808028 [No Abstract] [Full Text] [Related]
10. Experimental models in cancer immunotherapy. Ross DS; Steele G J Surg Res; 1984 Nov; 37(5):415-30. PubMed ID: 6208411 [No Abstract] [Full Text] [Related]
11. Attempts to abolish tolerance of skin homografts in mice with x-irradiated plasma from specifically sensitized donors. Lubaroff DM; Silvers WK J Immunol; 1971 Apr; 106(4):1122-4. PubMed ID: 4928745 [No Abstract] [Full Text] [Related]
12. Role of activated macrophages in nonspecific resistance to neoplasia. Hibbs JB J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879 [No Abstract] [Full Text] [Related]
13. Tolerance to myocardial tissue allografts by pretreatment with cross-reactive streptococcal membrane antigen. Ellis RJ; Zabriskie JB; Ebert PA Surgery; 1974 Jul; 76(1):142-9. PubMed ID: 4601598 [No Abstract] [Full Text] [Related]
14. Immunotherapy of malignant disease. Nadler SH; Moore GE Arch Surg; 1969 Sep; 99(3):376-81. PubMed ID: 5798432 [No Abstract] [Full Text] [Related]
16. [Graft rejection and its mechanism]. Păuşescu E Fiziol Norm Patol; 1973; 19(2):97-116. PubMed ID: 4573770 [No Abstract] [Full Text] [Related]
17. Principles of immunity. II. Cellular immunology and immunogenetics. Zink GL Am J Pharm Sci Support Public Health; 1974; 146(5):138-49. PubMed ID: 4155603 [No Abstract] [Full Text] [Related]
18. The role of immunological enhancement for the growth of autochthonous tumors. Hellström I; Hellström KE Transplant Proc; 1971 Mar; 3(1):721-4. PubMed ID: 4106337 [No Abstract] [Full Text] [Related]
19. Immunity to malignant disease in man. Fairley GH Sci Basis Med Annu Rev; 1971; ():17-38. PubMed ID: 4933915 [No Abstract] [Full Text] [Related]